Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
6,399
-
Share change
-
-52,126
-
Total reported value
-
$4,000
-
Price per share
-
$0.71
-
Number of holders
-
3
-
Value change
-
-$58,661
-
Number of sells
-
5
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q3 2022
As of 30 Sep 2022,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,399 shares.
The largest 4 holders included
CITADEL ADVISORS LLC, VALLEY NATIONAL ADVISERS INC, Federation des caisses Desjardins du Quebec, and BANK OF AMERICA CORP /DE/.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.